Conmed Weighs Sale After Receiving Takeover Interest
CNMD sits 27% above its 52-week low of $31.44 on elevated volume (2.7× avg).
Summary
Conmed is exploring a sale after attracting takeover interest, per Bloomberg. The medical device maker has a market cap around $1.16B and recently strengthened its board with industry veterans from J&J and Boston Scientific. This follows a series of financial moves including a $450M term loan and a $645M convertible note repurchase, suggesting active balance sheet management. A sale process could attract strategic or private equity buyers given Conmed's position in surgical instruments. No formal timeline or bidders have been named.
At the time of this announcement, CNMD was trading at $40.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $31.44 to $56.64. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.